ZA200802763B - Compositions and methods for preparation of poorly water soluble drugs with increased stability - Google Patents
Compositions and methods for preparation of poorly water soluble drugs with increased stabilityInfo
- Publication number
- ZA200802763B ZA200802763B ZA200802763A ZA200802763A ZA200802763B ZA 200802763 B ZA200802763 B ZA 200802763B ZA 200802763 A ZA200802763 A ZA 200802763A ZA 200802763 A ZA200802763 A ZA 200802763A ZA 200802763 B ZA200802763 B ZA 200802763B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- preparation
- methods
- water soluble
- increased stability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71286505P | 2005-08-31 | 2005-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200802763B true ZA200802763B (en) | 2009-10-28 |
Family
ID=41449779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200802763A ZA200802763B (en) | 2005-08-31 | 2006-08-30 | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
Country Status (3)
Country | Link |
---|---|
NO (1) | NO344525B1 (en) |
UA (3) | UA108840C2 (en) |
ZA (1) | ZA200802763B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
CA2362338A1 (en) * | 1998-07-30 | 2000-02-10 | Human Rt. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
SI21222A (en) * | 2002-05-28 | 2003-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Method for preparation of nanoparticles |
EP3470084A1 (en) * | 2002-12-09 | 2019-04-17 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
US7674816B2 (en) * | 2003-12-23 | 2010-03-09 | Abraxis Bioscience, Llc | Substituted melatonin derivatives, process for their preparation, and methods of use |
-
2006
- 2006-08-30 UA UAA201109120A patent/UA108840C2/en unknown
- 2006-08-30 UA UAA200803884A patent/UA95921C2/en unknown
- 2006-08-30 UA UAA200803886A patent/UA96273C2/en unknown
- 2006-08-30 ZA ZA200802763A patent/ZA200802763B/en unknown
-
2019
- 2019-03-06 NO NO20190306A patent/NO344525B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA108840C2 (en) | 2015-06-25 |
NO344525B1 (en) | 2020-01-27 |
UA95921C2 (en) | 2011-09-26 |
NO20190306A1 (en) | 2008-05-13 |
UA96273C2 (en) | 2011-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272236A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
IL286802A (en) | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases | |
IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
ZA200707898B (en) | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases | |
ZA200900345B (en) | Preparation of pharmaceutical formulations | |
EP1933862A4 (en) | Methods and compositions for oral administration of proteins | |
IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
IL190885A0 (en) | Immunogenic compositions and methods of use | |
EP2024272A4 (en) | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same | |
HK1117519A1 (en) | Substituted benzimidazoles and methods of preparation | |
IL195491A (en) | Pharmaceutical compositions of tmc278 and processes for their preparation | |
IL198513A0 (en) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | |
IL193211A (en) | Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them | |
IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
EP2051721A4 (en) | Preparation and pharmaceutical use of euterpe oleracea (acai) extract compositions | |
IL188278A0 (en) | Water soluble analgesic formulations and methods for production | |
IL191922A0 (en) | Pharmaceutical formulations of oxcarbazepine and methods for its preparation | |
IL186277A0 (en) | Dnt-maleate and methods of preparation thereof | |
ZA200802763B (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
GB2452142A8 (en) | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sa | |
IL191861A0 (en) | Improved jasmonate derivatives, pharmaceutical compositions and methods of use thereof | |
IL192553A0 (en) | Dnt-fumarate and methods of preparation thereof | |
IL190726A0 (en) | Dnt-benzenesulfonate and methods of preparation thereof | |
IL198994A0 (en) | Use of incensole and incensole acetate for the preparation of pharmaceutical compositions |